查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439977

封堵器 - 全球市场回顾、竞争格局、市场预测 (2030)

Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计 2024 年至 2030 年预测期内，全球封堵器市场规模将以 6.31% 的复合年增长率成长。 封堵器的需求主要是由患有各种慢性病的目标患者群体不断增加所推动的。 此外，快速的技术发展、对微创手术 (MIS) 的需求不断增加、微创手术有利的报销方案以及老年人口的增加等，将有助于 2024-2030 年预测期内的整体市场成长。

咬合架市场动态

由于多种因素，封堵器市场的产品需求正在成长，其中主要因素之一是心血管疾病盛行率的增加。

例如，英国心臟基金会 (2023) 报告称，到 2022 年，全球将有约 5.5 亿人患有心臟病和循环系统疾病。 文件也显示，到2022年，缺血性心臟病将成为最常见的心血管疾病之一，影响全球2亿人，其次是周边动脉（血管）疾病，将影响1.1亿人，中风将影响1亿人， 6000 万人患有心房颤动。 心血管疾病的增加导致外科手术的增加，解闭塞装置可去除动脉中的斑块形成并治癒疾病。

微创手术比心臟直视手术疤痕更少、疼痛更少、癒合更快，因此对微创手术的需求正在导致封堵器市场需求的增加。 此外，封堵器可以帮助避免与手术相关的缺点，例如支架放置后的疤痕和发炎。

根据世界卫生组织 (WHO) (2022) 的数据，2020 年全球约有 226 万人新诊断出乳癌。 同数据显示，2020年新增肺癌221万例、皮肤癌120万例、摄护腺癌141万例、胃癌109万例。 对于一些无法透过手术切除肿瘤的患者来说，栓塞是一种安全的选择，因为它会减少流向癌细胞的血流。 化疗栓塞也是肝癌的一种安宁疗护方法，它可以阻断动脉并帮助将化疗药物保留在肝臟中。 因此，癌症发生率的增加可能会增加未来几年对封堵装置的需求。

因此，上述因素将导致未来几年对封堵器的需求增加，从而提高预测期内（2024-2030 年）封堵器的整体市场成长。

然而，手术相关併发症、严格的监管框架等可能会对封堵器市场的成长带来挑战。

COVID-19 大流行对封堵器市场产生了重大影响。 造成这种情况的主要原因之一是世界各地严格的封锁导致医疗保健系统的重组。 COVID-19 患者的治疗也被列为优先事项。 患有各种慢性疾病，特别是瓣膜性心臟病的患者被认为是不紧急的，导致治疗延误。 此外，重症监护病房床位的短缺对某些手术（包括使用封堵装置的治疗）来说是一个真正的挑战。 除了供应链限制和缺乏熟练专业人员外，设备分销也受到限制，这反过来又影响了对封锁设备的需求。 然而，随着解封后活动的恢復和疫苗的接种，患者开始到医院和诊所接受各种慢性疾病的治疗，包括癌症和心血管疾病，导致对封堵器的需求增加。设备市场已步入正轨。

咬合架细分市场分析

在封堵器市场的应用领域，神经系统类别预计将在 2023 年占据重要的收入占有率。

脑动脉瘤盛行率的上升以及利用先进技术的新产品的推出预计将推动整体市场的成长。

例如，根据脑动脉瘤基金会 2021 年的估计，美国每年约有 30,000 人患有脑动脉瘤破裂。

同一份文件指出，女性，尤其是 55 岁以上的女性，脑动脉瘤破裂的风险高于男性。 随着人口老化的增加，预计这种风险在未来将会增加。

本报告研究和分析了全球封堵器市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第一章封堵器市场报告简介

第 2 章封堵装置市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第三章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章封堵器市场主要因素分析

  • 占用设备市场驱动因素
  • 封堵器市场的限制与挑战
  • 封闭的设备市场机会

第五章波特封堵器市场五力分析

第六章封堵器市场布局

  • 产品类型
    • 栓塞装置
    • 闭塞清除装置
    • 支援设备
  • 依用途
    • 肿瘤
    • 心
    • 紧张
    • 其他
  • 按最终用户
    • 医院
    • 门诊手术中心
  • 地区
    • 北美封堵器市场规模（2021-2030 年）
    • 欧洲封堵器市场规模（2021-2030 年）
    • 亚太地区封堵器市场规模（2021-2030 年）
    • 其他地区封堵器市场规模（2021-2030 年）

第七章封堵器市场公司及产品概况

  • Abbott
  • Acrostak Int.
  • Terumo Corporation
  • Edwards Lifesciences Corporation
  • Cordis
  • B. Braun SE
  • Cook
  • Medtronic
  • Cardinal Health
  • AngioDynamics
  • Integer Holdings Corporation
  • Acandis GmbH
  • Penumbra, Inc.
  • LeMaitre Vascular Inc.
  • Lepu Medical
  • Stryker
  • Boston Scientific Corporation
  • Artio Medical Inc.
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • Kaneka Medix Corporation

第8章KOL浏览量

第 9 章专案方法

第 10 章关于 DelveInsight

第 11 章免责声明与联络我们

Product Code: DIMDCL0658

Occlusion Devices Market By Product Type (Embolization Devices, Occlusion Removal Devices [Coil Retrievers, Stent Retrievers, And Others], And Support Devices), By Application (Oncology, Cardiology, Neurology, And Others), By End-User (Hospitals, Ambulatory Surgical Centres, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of cardiovascular diseases, cancers, and other chronic diseases and the rising technological advancements in the occlusion devices

The global occlusion devices market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030. The demand for occlusion devices is primarily being boosted by the increasing number of target patient populations suffering from various chronic illnesses. Furthermore, surging technological developments, rising demand for minimally invasive surgeries (MIS), suitable reimbursement scenarios for minimally invasive surgeries, and an increasing geriatric population among others have contributed to the overall growth of the occlusion devices market during the forecast period from 2024-2030.

Occlusion Devices Market Dynamics:

The occlusion devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of cardiovascular diseases.

For instance, British Heart Foundation (2023) reported that around 550 million people were living with heart and circulatory diseases in 2022, across the world. Further, the source stated that ischemic heart disease is one of the most common cardiovascular disorders, affecting 200 million people, followed by peripheral arterial (vascular) disease with 110 million people, stroke with 100 million people, and atrial fibrillation affecting 60 million people in 2022, globally. The increasing number of cardiovascular diseases will in turn increase the number of surgical procedures in which the occlusion removal devices will aid by removing the plaque formation in the arteries, thereby curing the ailment.

The demand for minimally invasive surgeries that offer less scarring reduced pain, and faster healing than open-heart surgeries has led to the growth of demand for occlusion devices in the market. Furthermore, occlusion devices help in avoiding disadvantages associated with surgical procedures such as surgical scarring and inflammation after stent implantation.

According to the World Health Organization (WHO) 2022, it was stated that approximately 2.26 million new instances of breast cancer were diagnosed worldwide, in 2020. According to the same source, 2.21 million new cases of lung cancer, 1.20 million cases of skin cancer, 1.41 million cases of prostate cancer, and 1.09 million cases of stomach cancer were reported worldwide, in 2020. Embolization is known to be a safe option for some patients with tumors that cannot be removed by surgery as these devices reduce the blood flow to cancer cells. Also, chemoembolization is a palliative treatment for liver cancer that helps in blocking the artery to let the chemotherapy drug stay in the liver. Thus, the increasing incidence of cancer will increase the demand for occlusion devices in the upcoming years.

Therefore, the factors mentioned above will lead to an increased demand for occlusion devices in the upcoming years, thereby raising the overall market growth for occlusion devices during the forecast period (2024-2030).

However, surgery-related complications, stringent regulatory framework, and others can impose a challenge to occlusion device market growth.

The COVID-19 pandemic had significantly impacted the occlusion devices market one of the major reasons being the reorganization of healthcare systems owing to strict lockdown imposition across the globe. Also, the treatment of patients suffering from covid-19 infection was a priority. Patients suffering from various chronic diseases, particularly those with heart valve diseases were considered non-urgent which led to delays in their treatment procedures. Further, the shortage of ICU beds also possessed a real challenge for several procedures involving occlusion device treatments. Along with the restriction in the supply chain and shortage of skilled professionals, there was a limit in the distribution of devices which ultimately affected the demand for occlusion devices. However, with the resumption of activities after the relaxation of the lockdown and with the vaccine administration, the patients started visiting hospitals and clinics for the treatment of various chronic diseases including cancer and cardiovascular diseases, leading to an increased demand for occlusion devices, thereby bring the market of occlusion devices on track.

Occlusion Devices Market Segment Analysis:

Occlusion Devices Market by Product Type (Embolization Devices, Occlusion Removal Devices [Coil Retrievers, Stent Retrievers, and Others], and Support Devices), Application (Oncology, Cardiology, Vascular Diseases, Neurology, and Others), End-User (Hospitals, Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the occlusion devices market, the neurology category is expected to amass a significant revenue share in the year 2023.

The rising prevalence of brain aneurysms and the launch of new technologically advanced products are expected to drive the overall growth of the market.

For instance, according to 2021 estimations done by the Brain Aneurysm Foundation, approximately 30,000 people in the United States suffer a brain aneurysm rupture each year.

The same source stated that women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men. This risk is expected to increase in the future as the geriatric population increases.

Further, blood artery damage or trauma, smoking, hypertension, and genetic susceptibility are all risk factors for the development of a brain aneurysm. Medical therapy, surgical clipping, endovascular therapy, or coiling without or with adjunctive devices are among the options for treating brain aneurysms. For instance, according to the WHO key statistics from August 2021, there were an estimated 1.28 billion adults worldwide, aged 30-79, who had hypertension, with the majority of them (two-thirds) residing in low- and middle-income countries. The increasing statistics of hypertension will increase the number of patients suffering from cardiovascular diseases, ultimately increasing the demand for occlusion devices used in the treatment of cardiovascular diseases.

Hence, owing to all the aforementioned factors, the market will experience an increased demand for neurology occlusion devices, thus growing the occlusion devices market during the forecast period.

North America is expected to dominate the overall Occlusion Devices Market:

Among all the regions, North America is estimated to account for the largest share of the occlusion devices market in the year 2023. Owing to key growth factors such as the rising prevalence of cardiovascular diseases, increasing cases of cancer, as well as neurological conditions like brain aneurysms, along with the soaring advancement in devices, and newer government initiatives regarding disease treatment awareness, are driving the North America occlusion devices market.

For instance, the Centers for Disease Control and Prevention (CDC) 2022, reported that every year, about 805,000 people in the United States suffer from heart attacks, especially among most racial and ethnic groups in the United States. As per, CDC 2021, about 18.2 million adults of age 20 years and older had coronary artery disease, and about 360,900 people died in 2019 due to coronary heart disease. As a result, more operations are anticipated due to the high mortality rate from cardiovascular diseases in the nation. This will likely lead to a rise in the usage of occlusion devices and support the expansion of the market.

Moreover, the rising prevalence of cancer in the US is also considered a key factor in the growing demand for occlusion devices.

In 2023, the American Cancer Society reported that in the United States 2023, nearly 1,958,310 new cancer cases are projected to occur. The increasing incidence of cancer is expected to drive the demand for interventional procedures in the region, thereby increasing the demand for occlusion devices as these devices work by stopping the blood flow toward tumors.

Therefore, the presence of a massive patient population suffering from various diseases correlates with an increase in product demand which supports the growth of the United States occlusion devices market as well as the overall North America occlusion devices market during the forecast period from 2024-2030.

Hence, the above-mentioned factors are going to generate considerable revenue thereby pushing the overall growth of the occlusion devices market in the North America region during the forecast period.

Occlusion Devices Market Key Players:

Some of the key market players operating in the occlusion devices market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.

Recent Developmental Activities in the Occlusion Devices Market:

In February 2022, Front Line Medical Technologies announced the availability and distribution of COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) which is strong enough to hold back aortic pressure and allows for permissive hypotension in bleeding areas below the balloon, thus decreasing chances of hemorrhage. It is the smallest life-saving bleeding control device.

In July 2021, Terumo Medical Corporation (TMC) announced the introduction of its AZUR Vascular Plug, the only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter.

In September 2020, Boston Scientific Corporation received U.S. Food & Drug Administration (FDA) approval to launch WATCHMAN FLX, which is a Left Atrial Appendage Closure (LAAC) device. It is designed to seal off Heart's left atrial appendage to prevent blood clot formation.

Key Takeaways from the Occlusion Devices Market Report Study

Market size analysis for current occlusion devices market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global occlusion devices market.

Various opportunities available for the other competitor in the occlusion devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current occlusion devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for occlusion devices market growth in the coming future?

Target Audience who can be benefited from this Occlusion Devices Market Report Study

Occlusion devices products providers

Research organizations and consulting companies

Occlusion devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in occlusion devices

Various End-users who want to know more about the occlusion devices market and the latest technological developments in the occlusion devices market.

Frequently Asked Questions for the Occlusion Devices Market:

1. What is an occlusion device?

Occlusion devices are used to create occlusion in the vessels to stop the blood flow.

2. What is the market for global occlusion devices?

The global occlusion devices market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030.

3. What are the drivers for global occlusion devices market?

The demand for occlusion devices is primarily being boosted by the rising prevalence of cardiovascular diseases, cancers, and other chronic diseases. Further, the rising adoption of minimally invasive devices, increasing geriatric population base, innovations in product development, and others will increase the demand for the overall growth of the occlusion devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global occlusion devices market?

Some of the key market players operating in the occlusion devices market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.

5. Which region has the highest share in the occlusion devices market?

North America is expected to dominate the overall occlusion devices market during the forecast period, 2024 to 2030. Factors such as the rising prevalence of cardiovascular diseases, cancers, and other chronic diseases, the rising geriatric population, and better healthcare infrastructure have had an immense effect on the growth of occlusion devices in the North America market. Furthermore, the rise in research to validate the efficacy of occlusion devices and the growing preference for minimally invasive devices also helped the market growth in this region.

Table of Contents

1.Occlusion Devices Market Report Introduction

2. Occlusion Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Occlusion Devices Market Key Factors Analysis

  • 4.1. Occlusion Devices Market Drivers
    • 4.1.1. Rising number of surgical procedures owing to the increasing number of chronic diseases
    • 4.1.2. Increasing preference for minimally invasive surgery
    • 4.1.3. Technological advancements in product development
  • 4.2. Occlusion Devices Market Restraints and Challenges
    • 4.2.1. Surgery-Related Complications
    • 4.2.2. Stringent regulatory framework
  • 4.3. Occlusion Devices Market Opportunities
    • 4.3.1. Advancements in the materials and configurations of occlusion devices

5. Occlusion Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Occlusion Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Embolization Devices
    • 6.1.2. Occlusion Removal Devices
      • 6.1.2.1. Coil Retrievers
      • 6.1.2.2. Stent Retrievers
      • 6.1.2.3. Others
    • 6.1.3. Support Devices
  • 6.2. By Application
    • 6.2.1. Oncology
    • 6.2.2. Cardiology
    • 6.2.3. Neurology
    • 6.2.4. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of the Asia-Pacific Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Occlusion Devices Market Size in USD million (2021-2030)

7. Occlusion Devices Market Company and Product Profiles

    • 7.1.1. Abbott
      • 7.1.1.1. Company Overview
      • 7.1.1.2. Company Snapshot
      • 7.1.1.3. Financial Overview
      • 7.1.1.4. Product Listing
      • 7.1.1.5. Entropy
    • 7.1.2. Acrostak Int.
      • 7.1.2.1. Company Overview
      • 7.1.2.2. Company Snapshot
      • 7.1.2.3. Financial Overview
      • 7.1.2.4. Product Listing
      • 7.1.2.5. Entropy
    • 7.1.3. Terumo Corporation
      • 7.1.3.1. Company Overview
      • 7.1.3.2. Company Snapshot
      • 7.1.3.3. Financial Overview
      • 7.1.3.4. Product Listing
      • 7.1.3.5. Entropy
    • 7.1.4. Edwards Lifesciences Corporation
      • 7.1.4.1. Company Overview
      • 7.1.4.2. Company Snapshot
      • 7.1.4.3. Financial Overview
      • 7.1.4.4. Product Listing
      • 7.1.4.5. Entropy
    • 7.1.5. Cordis
      • 7.1.5.1. Company Overview
      • 7.1.5.2. Company Snapshot
      • 7.1.5.3. Financial Overview
      • 7.1.5.4. Product Listing
      • 7.1.5.5. Entropy
    • 7.1.6. B. Braun SE
      • 7.1.6.1. Company Overview
      • 7.1.6.2. Company Snapshot
      • 7.1.6.3. Financial Overview
      • 7.1.6.4. Product Listing
      • 7.1.6.5. Entropy
    • 7.1.7. Cook
      • 7.1.7.1. Company Overview
      • 7.1.7.2. Company Snapshot
      • 7.1.7.3. Financial Overview
      • 7.1.7.4. Product Listing
      • 7.1.7.5. Entropy
    • 7.1.8. Medtronic
      • 7.1.8.1. Company Overview
      • 7.1.8.2. Company Snapshot
      • 7.1.8.3. Financial Overview
      • 7.1.8.4. Product Listing
      • 7.1.8.5. Entropy
    • 7.1.9. Cardinal Health
      • 7.1.9.1. Company Overview
      • 7.1.9.2. Company Snapshot
      • 7.1.9.3. Financial Overview
      • 7.1.9.4. Product Listing
      • 7.1.9.5. Entropy
    • 7.1.10. AngioDynamics
      • 7.1.10.1. Company Overview
      • 7.1.10.2. Company Snapshot
      • 7.1.10.3. Financial Overview
      • 7.1.10.4. Product Listing
      • 7.1.10.5. Entropy
    • 7.1.11. Integer Holdings Corporation
      • 7.1.11.1. Company Overview
      • 7.1.11.2. Company Snapshot
      • 7.1.11.3. Financial Overview
      • 7.1.11.4. Product Listing
      • 7.1.11.5. Entropy
    • 7.1.12. Acandis GmbH
      • 7.1.12.1. Company Overview
      • 7.1.12.2. Company Snapshot
      • 7.1.12.3. Financial Overview
      • 7.1.12.4. Product Listing
      • 7.1.12.5. Entropy
    • 7.1.13. Penumbra, Inc.
      • 7.1.13.1. Company Overview
      • 7.1.13.2. Company Snapshot
      • 7.1.13.3. Financial Overview
      • 7.1.13.4. Product Listing
      • 7.1.13.5. Entropy
    • 7.1.14. LeMaitre Vascular Inc.
      • 7.1.14.1. Company Overview
      • 7.1.14.2. Company Snapshot
      • 7.1.14.3. Financial Overview
      • 7.1.14.4. Product Listing
      • 7.1.14.5. Entropy
    • 7.1.15. Lepu Medical
      • 7.1.15.1. Company Overview
      • 7.1.15.2. Company Snapshot
      • 7.1.15.3. Financial Overview
      • 7.1.15.4. Product Listing
      • 7.1.15.5. Entropy
    • 7.1.16. Stryker
      • 7.1.16.1. Company Overview
      • 7.1.16.2. Company Snapshot
      • 7.1.16.3. Financial Overview
      • 7.1.16.4. Product Listing
      • 7.1.16.5. Entropy
    • 7.1.17. Boston Scientific Corporation
      • 7.1.17.1. Company Overview
      • 7.1.17.2. Company Snapshot
      • 7.1.17.3. Financial Overview
      • 7.1.17.4. Product Listing
      • 7.1.17.5. Entropy
    • 7.1.18. Artio Medical Inc.
      • 7.1.18.1. Company Overview
      • 7.1.18.2. Company Snapshot
      • 7.1.18.3. Financial Overview
      • 7.1.18.4. Product Listing
      • 7.1.18.5. Entropy
    • 7.1.19. KYOTO MEDICAL PLANNING Co., Ltd.
      • 7.1.19.1. Company Overview
      • 7.1.19.2. Company Snapshot
      • 7.1.19.3. Financial Overview
      • 7.1.19.4. Product Listing
      • 7.1.19.5. Entropy
    • 7.1.20. Kaneka Medix Corporation
      • 7.1.20.1. Company Overview
      • 7.1.20.2. Company Snapshot
      • 7.1.20.3. Financial Overview
      • 7.1.20.4. Product Listing
      • 7.1.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Occlusion Devices Market in Global (2021-2030)
  • Table 3: Occlusion Devices Market in Global by Product Type (2021-2030)
  • Table 4: Occlusion Devices Market in Global by Application (2021-2030)
  • Table 5: Occlusion Devices Market in Global by End-User (2021-2030)
  • Table 6: Occlusion Devices Market in Global by Geography (2021-2030)
  • Table 7: Occlusion Devices Market in North America (2021-2030)
  • Table 8: Occlusion Devices Market in North America by Country (2021-2030)
  • Table 9: Occlusion Devices Market in the US (2021-2030)
  • Table 10: Occlusion Devices Market in Canada (2021-2030)
  • Table 11: Occlusion Devices Market in Mexico (2021-2030)
  • Table 12: Occlusion Devices Market in Europe (2021-2030)
  • Table 13: Occlusion Devices Market in Europe by Country (2021-2030)
  • Table 14: Occlusion Devices Market in France (2021-2030)
  • Table 15: Occlusion Devices Market in Germany (2021-2030)
  • Table 16: Occlusion Devices Market in the United Kingdom (2021-2030)
  • Table 17: Occlusion Devices Market in Italy (2021-2030)
  • Table 18: Occlusion Devices Market in Spain (2021-2030)
  • Table 19: Occlusion Devices Market in the Rest of Europe (2021-2030)
  • Table 20: Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Table 21: Occlusion Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Occlusion Devices Market in China (2021-2030)
  • Table 23: Occlusion Devices Market in Japan (2021-2030)
  • Table 24: Occlusion Devices Market in India (2021-2030)
  • Table 25: Occlusion Devices Market in Australia (2021-2030)
  • Table 26: Occlusion Devices Market in South Korea (2021-2030)
  • Table 27: Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Occlusion Devices Market in the Rest of the World (2021-2030)
  • Table 29: Occlusion Devices Market in RoW by Region (2021-2030)
  • Table 30: Occlusion Devices Market in the Middle East (2021-2030)
  • Table 31: Occlusion Devices Market in Africa (2021-2030)
  • Table 32: Occlusion Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Occlusion Devices Market in Global (2021-2030)
  • Figure 3: Occlusion Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Occlusion Devices Market in Global by Application (2021-2030)
  • Figure 5: Occlusion Devices Market in Global by End-User (2021-2030)
  • Figure 6: Occlusion Devices Market in Global by Geography (2021-2030)
  • Figure 7: Occlusion Devices Market in North America (2021-2030)
  • Figure 8: Occlusion Devices Market in North America by Country (2021-2030)
  • Figure 9: Occlusion Devices Market in the US (2021-2030)
  • Figure 10: Occlusion Devices Market in Canada (2021-2030)
  • Figure 11: Occlusion Devices Market in Mexico (2021-2030)
  • Figure 12: Occlusion Devices Market in Europe (2021-2030)
  • Figure 13: Occlusion Devices Market in Europe by Country (2021-2030)
  • Figure 14: Occlusion Devices Market in France (2021-2030)
  • Figure 15: Occlusion Devices Market in Germany (2021-2030)
  • Figure 16: Occlusion Devices Market in the United Kingdom (2021-2030)
  • Figure 17: Occlusion Devices Market in Italy (2021-2030)
  • Figure 18: Occlusion Devices Market in Spain (2021-2030)
  • Figure 19: Occlusion Devices Market in the Rest of Europe (2021-2030)
  • Figure 20: Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Figure 21: Occlusion Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Occlusion Devices Market in China (2021-2030)
  • Figure 23: Occlusion Devices Market in Japan (2021-2030)
  • Figure 24: Occlusion Devices Market in India (2021-2030)
  • Figure 25: Occlusion Devices Market in Australia (2021-2030)
  • Figure 26: Occlusion Devices Market in South Korea (2021-2030)
  • Figure 27: Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Occlusion Devices Market in the Rest of the World (2021-2030)
  • Figure 29: Occlusion Devices Market in RoW by Region (2021-2030)
  • Figure 30: Occlusion Devices Market in the Middle East (2021-2030)
  • Figure 31: Occlusion Devices Market in Africa (2021-2030)
  • Figure 32: Occlusion Devices Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis